Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma

被引:43
作者
Li, W [1 ]
Xu, RJ
Jiang, LH
Shi, JF
Long, X
Fan, B
机构
[1] First Peoples Hosp Hangzhou, Dept Gynecol & Obstet, Hangzhou 310006, Zhejiang, Peoples R China
[2] First Peoples Hosp Hangzhou, Dept Pathol, Hangzhou 310006, Zhejiang, Peoples R China
关键词
cyclooxygenase; inducible nitric oxide synthase; endometrial carcinoma; tumor angiogenesis; immunohistochemistry;
D O I
10.1385/MO:22:1:063
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study evaluated the significance of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in 30 patients with endometrial carcinoma and the relationship of those molecular markers to tumor characteristics and microvessel density (MVD). Immunohistochemical expression of COX-2, iNOS, and CD34 was analyzed on paraffin-embedded tissue sections. The COX-2 and iNOS positive rates were 66.7% and 73.3%, respectively. The level of COX-2 expression was higher in grade 11 tumors than in grade III tumors (p < 0.05). The percentage of iNOS positivity was higher in patients with deep myometrial invasion than in patients without or less than 50% myometrial invasion (p < 0.05). There was significant correlation between positive COX-2 and positive iNOS expression (r = 0.601, p < 0.001). Both COX-2 and iNOS were significantly correlated with MVD (r = 0.02 p < 0.05; r = 0.599 p < 0.0001, respectively). The present findings suggest that combined expression of COX-2 and iNOS may play an important role in development and invasion of endometrial cancer and that this could be partially attributable to modulation of angiogenesis by COX-2 and iNOS.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 43 条
  • [1] Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression
    Ambs, S
    Hussain, SP
    Harris, CC
    [J]. FASEB JOURNAL, 1997, 11 (06) : 443 - 448
  • [2] Battu S, 1998, ANTICANCER RES, V18, P3579
  • [3] Eroglu A, 1999, BRIT J CANCER, V80, P1630
  • [4] Cyclooxygenase-2 expression in endometrial carcinoma - Correlation with clinicopathologic parameters and clinical outcome
    Ferrandina, G
    Legge, F
    Ranelletti, FO
    Zannoni, GF
    Maggiano, N
    Evangelisti, A
    Mancuso, S
    Scambia, G
    Lauriola, L
    [J]. CANCER, 2002, 95 (04) : 801 - 807
  • [5] Cyclooxygenase-2 expression in endometrial cancer: Correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase
    Fujiwaki, R
    Iida, K
    Kanasaki, H
    Ozaki, T
    Hata, K
    Miyazaki, K
    [J]. HUMAN PATHOLOGY, 2002, 33 (02) : 213 - 219
  • [6] Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer
    Fujiwaki, R
    Hata, K
    Iida, K
    Koike, M
    Miyazaki, K
    [J]. GYNECOLOGIC ONCOLOGY, 1998, 68 (03) : 247 - 252
  • [7] Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer
    Fujiwaki, R
    Hata, K
    Iida, K
    Maede, Y
    Watanabe, Y
    Koike, M
    Miyazaki, K
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1999, 78 (08) : 728 - 734
  • [8] Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
    Hanahan, D
    Folkman, J
    [J]. CELL, 1996, 86 (03) : 353 - 364
  • [9] Jaiswal M, 2000, CANCER RES, V60, P184
  • [10] Klimp AH, 2001, CANCER RES, V61, P7305